Principal Financial Group’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$307K Buy
5,275
+343
+7% +$18.6K ﹤0.01% 2069
2025
Q4
$228K Sell
4,932
-3,062
-38% -$137K ﹤0.01% 2115
2025
Q3
$288K Sell
7,994
-618
-7% -$20.5K ﹤0.01% 2125
2025
Q2
$280K Sell
8,612
-460,949
-98% -$15.1M ﹤0.01% 2083
2025
Q1
$17.7M Buy
469,561
+160,622
+52% +$12.8M 0.01% 907
2024
Q4
$25.3M Buy
308,939
+256,237
+486% +$25.4M 0.01% 723
2024
Q3
$6.02M Buy
52,702
+34,287
+186% +$3.09M ﹤0.01% 1499
2024
Q2
$1.39M Sell
18,415
-6,182
-25% -$421K ﹤0.01% 1818
2024
Q1
$1.68M Buy
24,597
+2,589
+12% +$179K ﹤0.01% 1800
2023
Q4
$1.38M Buy
22,008
+376
+2% +$19.5K ﹤0.01% 1802
2023
Q3
$1.1M Sell
21,632
-524
-2% -$25.9K ﹤0.01% 1828
2023
Q2
$1.11M Buy
22,156
+4,848
+28% +$230K ﹤0.01% 1831
2023
Q1
$649K Sell
17,308
-1,154
-6% -$49K ﹤0.01% 1917
2022
Q4
$885K Buy
18,462
+4,190
+29% +$164K ﹤0.01% 1875
2022
Q3
$342K Sell
14,272
-225
-2% -$5.7K ﹤0.01% 2046
2022
Q2
$315K Buy
+14,497
New +$335K ﹤0.01% 2163
2021
Q4
Sell
-10,121
Closed -$257K 2600
2021
Q3
$257K Sell
10,121
-1,641
-14% -$39.8K ﹤0.01% 2349
2021
Q2
$265K Buy
11,762
+448
+4% +$9.17K ﹤0.01% 2400
2021
Q1
$223K Buy
11,314
+797
+8% +$20.1K ﹤0.01% 2354
2020
Q4
$279K Buy
+10,517
New +$391K ﹤0.01% 2252

Other funds holding PCVX